期刊文献+

生存素在肿瘤中的作用及其耐药机制 被引量:1

Roles and resistance mechanisms of survivin in tumor
原文传递
导出
摘要 肿瘤治疗中的耐药问题是影响疾病转归的重要因素,目前已有大量研究发现,生存素(survivin)具有抑制肿瘤细胞凋亡、调控肿瘤细胞周期、促进血管生成、促进肿瘤转移的作用,并可与多种基因及蛋白相互作用,影响肿瘤细胞耐药性. Drug resistance in tumor treatment is an important factor that affects disease outcome. A lot of researches show that survivin can inhibit tumor cell apoptosis, regulate cell cycle, promote angiogenesis and tumor metastasis. The interactions among survivin, genes and proteins can influence the drug resistance of tumor cells.
出处 《国际肿瘤学杂志》 CAS 2014年第4期241-244,共4页 Journal of International Oncology
基金 天津市自然科学基金(11JCZDJC28000)
关键词 抗药性 肿瘤 肿瘤 多药耐药相关蛋白质类 生存素 Drug resistance, neoplasm Neoplasms Multidrug resistance-associated proteins Survivin
  • 相关文献

参考文献26

  • 1Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door[J]. Nat Rev Mol Cell Biol, 2002, 3(6) : 401-410.
  • 2Verdecia MA, Huang H, Dutil E, et al. Structure of the human anti- apoptotic protein survivin reveals a dimeric arrangement [ J ]. Nat Struct Biol, 2000, 7(7) : 602-608.
  • 3Li F, Ackermann E J, Bennett CF, et al. Pleiotropic cell-divisiondefects and apoptosis induced by interference with survivin function [J]. Nat Cell Siol, 1999, 1(8) : 461-466.
  • 4Wang L, Yin F, Du Y, et al. Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin [ J ~. Tumour Biol, 2010, 31(3): 225-232.
  • 5Wang P, Zhen H, Zhang J, et al. Survivin promotes glioma angiogen- esis through vascular endothelial growth factor and basic fibroblast growth factor in vitro and in vivo[J]. Mol Carcinog, 2012, 51 (7) : 586-595.
  • 6Li Z, Yang S, Chang T, et al. Anti-angiogenesis and anticancer effects of a plasmid expressing both ENDO-VEGI151 and small inter- fering RNA against survivin[ J]. Int J Mol Med, 2012, 29(3) : 485- 490.
  • 7Lee J, Choi JH, Joo CK. TGF-[31 regulates cell fate during epithelial- mesenchymal transition by upregulating survivin [ J ]. Cell Death Dis, 2013, 4: e714.
  • 8Ye Q, Cai W, Zheng Y, et al. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer [ J ]. Oncogene, 2013, In press.
  • 9Sos ML, Koker M, Weir BA, et al. PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR [J]. Cancer Res, 2009, 69(8): 3256-3261.
  • 10Yamamoto C, Basaki Y, Kawahara A, et al. Loss of PTEN expres- sion by blocking nuclear translocation of EGR1 in gefitinib-resistant lung cancer cells harboring epidermal growth factor receptor-activa- ting mutations[ J]. Cancer Res, 2010, 70(21 ) : 8715-8725.

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部